{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:03:03Z","timestamp":1770292983688,"version":"3.49.0"},"reference-count":70,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Thyroid hormones regulate energy homeostasis, lipid\/glucose metabolism, and protein turnover. Chronic Hepatitis C Virus (HCV) infection is highly associated with autoimmune hypothyroidism, which may have profound metabolic implications. This study evaluates thyroid dysfunction and anti-thyroid peroxidase (anti-TPO) autoimmunity in HCV patients and explores its potential metabolic implications in a high-prevalence region. Methods: In this comparative cross-sectional study adhering to STROBE guidelines, we enrolled 100 PCR-confirmed chronic HCV patients and 100 age\/gender-matched controls from District Peshawar, Pakistan. Serum TSH, fT3, fT4, and anti-TPO antibodies were quantified. Multivariable logistic regression, adjusted for age, gender, and viral load, was used to compute adjusted odds ratios (aOR) with 95% confidence intervals (CI). Results: Thyroid dysfunction affected 41% of HCV patients vs. 12% of controls (aOR 5.2, 95% CI 2.8\u20139.6, p &lt; 0.001), predominantly hypothyroidism (29% overall; 18% overt, 11% subclinical). Anti-TPO positivity was 38% in HCV vs. 8% in controls (aOR 6.7, 95% CI 3.1\u201314.5, p &lt; 0.001). Anti-TPO titers correlated positively with TSH (r = +0.62, p &lt; 0.001) and inversely with fT3\/fT4. Subgroup analysis showed higher dysfunction in patients aged \u226540 years (52% vs. 28%, p = 0.012) and viral load \u2265 106 IU\/mL (48% vs. 32%, p = 0.041). We hypothesize that these findings may have significant metabolic implications, including impaired mitochondrial \u03b2-oxidation and insulin resistance. Conclusions: HCV infection is strongly associated with autoimmune hypothyroidism, which may amplify cardiometabolic risk. The paper has not explicitly identified metabolic parameters, including lipid profiles, indices of insulin resistance, and metabolomic signatures, and, therefore, any metabolic inferences are speculative and based on established thyroid and HCV pathophysiology. Routine thyroid screening pre- and post-DAA therapy is recommended, alongside metabolomic profiling to validate these proposed metabolic pathways.<\/jats:p>","DOI":"10.3390\/metabo16020104","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:00:33Z","timestamp":1770022833000},"page":"104","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus Infection Induces Autoimmune Hypothyroidism with Potential Profound Metabolic Implications: A Cross-Sectional Study in a High-Prevalence Region"],"prefix":"10.3390","volume":"16","author":[{"given":"Xiaoli","family":"Zhong","sequence":"first","affiliation":[{"name":"School of Health and Wellness, University of Panzhihua, Panzhihua 617000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Abbas","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Malakand Campus, Chakdara 23050, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farman","family":"Ullah","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Malakand Campus, Chakdara 23050, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafi","family":"Ullah","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Malakand Campus, Chakdara 23050, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI29812","article-title":"Deiodinases: Implications of the local control of thyroid hormone action","volume":"116","author":"Bianco","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_4","unstructured":"Visser, T.J. (2015). Cellular Uptake of Thyroid Hormones, MDText.com, Inc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"key":"ref_6","first-page":"601","article-title":"Pharmacoepidemiology and drug safety 2006; 15: i\u2013xii","volume":"26","author":"Antons","year":"2006","journal-title":"Pharmacotherapy"},{"key":"ref_7","first-page":"107","article-title":"Infection, thyroid disease, and autoimmunity","volume":"14","author":"Tomer","year":"1993","journal-title":"Endocr. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Songtanin, B., and Nugent, K. (2022). Burden, outcome, and comorbidities of extrahepatic manifestations in hepatitis C virus infection. Biology, 12.","DOI":"10.3390\/biology12010023"},{"key":"ref_9","first-page":"321","article-title":"Endocrine manifestations of chronic HCV infection","volume":"40","author":"Caviglia","year":"2015","journal-title":"Minerva Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jmv.21269","article-title":"Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection","volume":"80","author":"Quadros","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-\u03b1 and autoimmune thyroid disease","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lasa, M., and Contreras-Jurado, C. (2022). Thyroid hormones act as modulators of inflammation through their nuclear receptors. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.937099"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, Y., and Li, W. (2025). Viral infection and thyroid disorders: A narrative review. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1625179"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00619-16","article-title":"HCV-induced upregulation of miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis","volume":"90","author":"Bandiera","year":"2016","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"C521","DOI":"10.1152\/ajpcell.00451.2021","article-title":"The CD38 glycohydrolase and the NAD sink: Implications for pathological conditions","volume":"322","author":"Kashyap","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.1997.7.891","article-title":"Interferon-\u03b1 induced thyroid dysfunction: Three clinical presentations and a review of the literature","volume":"7","author":"Koh","year":"1997","journal-title":"Thyroid"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_18","unstructured":"Aydin, C., and De\u011firmenci, M. (2024). Tiroid Kanserlerine G\u00fcncel Yakla\u015f\u0131m, Akademisyen Kitabevi."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199709058331","article-title":"Autoimmune phenomena and hepatitis C virus in lymphoproliferative and connective tissue disorders","volume":"28","author":"Bertero","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000380997","article-title":"A practical approach to hypocalcaemia in children","volume":"28","author":"Shaw","year":"2015","journal-title":"Endocr. Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3748\/wjg.v22.i4.1684","article-title":"Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data","volume":"22","author":"Umer","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.genrep.2024.101950","article-title":"STAT3 single-nucleotide variants in autoimmune thyroid disease in the Pakhtun population of Khyber Pakhtunkhwa, Pakistan","volume":"36","author":"Khan","year":"2024","journal-title":"Gene Rep."},{"key":"ref_23","first-page":"111","article-title":"Thyroid dysfunction in Khyber Pakhtunkhwa, Pakistan","volume":"32","author":"Attaullah","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12016-010-8245-8","article-title":"Cutting edge: The etiology of autoimmune thyroid diseases","volume":"41","author":"Eschler","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/138920211798120763","article-title":"Hashimoto\u2019s thyroiditis: From genes to the disease","volume":"12","author":"Zaletel","year":"2011","journal-title":"Curr. Genom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(08)61005-3","article-title":"Iodine-deficiency disorders","volume":"372","author":"Zimmermann","year":"2008","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5603\/EP.a2021.0017","article-title":"The rationale for selenium supplementation in patients with autoimmune thyroiditis, according to the current state of knowledge","volume":"72","author":"Filipowicz","year":"2021","journal-title":"Endokrynol. Pol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017018953","article-title":"Epidemiology of hepatitis C infection in Pakistan: Current estimate and major risk factors","volume":"27","author":"Arshad","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3748\/wjg.v28.i21.2251","article-title":"Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment","volume":"28","author":"Stella","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_30","first-page":"769","article-title":"Molecular actions of thyroid hormone","volume":"362","author":"Brent","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_31","first-page":"231","article-title":"The key roles of thyroid hormone in mitochondrial regulation, at interface of human health and disease","volume":"35","author":"Sagliocchi","year":"2024","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vastrad, B., and Vastrad, C. (2024). Identification of novel key genes and signaling pathways in hypertrophic cardiomyopathy: Evidence from bioinformatics and next generation sequencing data analysis. bioRxiv, preprint.","DOI":"10.1101\/2024.08.15.608116"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1210\/jc.2006-0478","article-title":"Insulin action in adipose tissue and muscle in hypothyroidism","volume":"91","author":"Dimitriadis","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","unstructured":"Bansal, N., and Weinstock, R.S. (2016). Non-Diabetic Hypoglycemia, MDText.com, Inc."},{"key":"ref_36","first-page":"390","article-title":"Dyslipidemias and hypothyroidism","volume":"11","author":"Fretes","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3748\/wjg.v18.i3.212","article-title":"Hepatitis C virus induced insulin resistance impairs response to anti viral therapy","volume":"18","author":"Anis","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ismail, I.T., Elfert, A., Helal, M., Salama, I., El-Said, H., and Fiehn, O. (2020). Remodeling lipids in the transition from chronic liver disease to hepatocellular carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13010088"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yao, H., Li, K., Wei, J., Lin, Y., and Liu, Y. (2023). The contradictory role of branched-chain amino acids in lifespan and insulin resistance. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1189982"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kim, H., Lee, D.S., An, T.H., Park, H.J., Kim, W.K., Bae, K.H., and Oh, K.J. (2021). Metabolic spectrum of liver failure in type 2 diabetes and obesity: From NAFLD to NASH to HCC. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094495"},{"key":"ref_41","unstructured":"P\u00e9rez-San-Gregorio, M.\u00c1. (2020). Psychological Biomarker Profile. NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring, Springer."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liu, L., Wu, Q., Chen, Y., Gu, G., Gao, R., Peng, B., Wang, Y., Li, A., Guo, J., and Xu, X. (2022). Updated pharmacological effects, molecular mechanisms, and therapeutic potential of natural product geniposide. Molecules, 27.","DOI":"10.3390\/molecules27103319"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Moreno, E., Arias-Rico, J., Jim\u00e9nez-S\u00e1nchez, R.C., Estrada-Luna, D., Jim\u00e9nez-Osorio, A.S., Zafra-Rojas, Q.Y., Ariza-Ortega, J.A., Flores-Ch\u00e1vez, O.R., Morales-Castillejos, L., and Sandoval-Gallegos, E.M. (2022). Role of bioactive compounds in obesity: Metabolic mechanism focused on inflammation. Foods, 11.","DOI":"10.3390\/foods11091232"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12328-023-01809-7","article-title":"Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir","volume":"16","author":"Matsumoto","year":"2023","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0973-0354.157915","article-title":"Thyroid function and metabolic syndrome","volume":"12","author":"Agarwal","year":"2015","journal-title":"Thyroid Res. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14310\/horm.2002.1111035","article-title":"Thyroid hormones and aging","volume":"7","author":"Peeters","year":"2008","journal-title":"Hormones"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15407\/exp-oncology.2023.01.070","article-title":"Familial non-medullary thyroid carcinoma","volume":"45","author":"Guda","year":"2023","journal-title":"Exp. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"AASLD-IDSA hepatitis C guidance panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Missiroli, S., Perrone, M., Boncompagni, C., Borghi, C., Campagnaro, A., Marchetti, F., Anania, G., Greco, P., Fiorica, F., and Pinton, P. (2021). Targeting the NLRP3 inflammasome as a new therapeutic option for overcoming cancer. Cancers, 13.","DOI":"10.3390\/cancers13102297"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3748\/wjg.v20.i11.2825","article-title":"Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis","volume":"20","author":"Gallo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Vargas-Uricoechea, H. (2023). Molecular mechanisms in autoimmune thyroid disease. Cells, 12.","DOI":"10.3390\/cells12060918"},{"key":"ref_54","unstructured":"Omu, A.E. (2013). Pro-inflammatory cytokines, lipid metabolism and inflammation in gestational diabetes mellitus as cause of insulin resistance. Gestational Diabetes-Causes, Diagnosis and Treatment, IntechOpen."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol. Rev."},{"key":"ref_56","first-page":"38","article-title":"Thyroid gland and direct acting antivirals (DAAs) used to treat chronic hepatitis C. Is it a safe regimen","volume":"50","author":"Dyrka","year":"2022","journal-title":"Pol. Merkur. Lekarski"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kochman, J., Jakubczyk, K., Bargiel, P., and Janda-Milczarek, K. (2021). The influence of oxidative stress on thyroid diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10091442"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"San-Mill\u00e1n, I. (2023). The key role of mitochondrial function in health and disease. Antioxidants, 12.","DOI":"10.3390\/antiox12040782"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Geanta, M., Cucos, B., and Brand, A. (2024). Public Health Issues in Pharmacogenomics. Pharmacogenomics in Clinical Practice, Springer International Publishing.","DOI":"10.1007\/978-3-031-45903-0_18"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ji, S., Zhou, Y., Zhao, Q., Chen, R., and Su, Z. (2024). Trends in three malnutrition factors in the global burden of disease: Iodine deficiency, vitamin A deficiency, and protein-energy malnutrition (1990\u20132019). Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1426790"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/lipidology1020008","article-title":"Lipid Profile Pitfalls in Subclinical Hypothyroidism Pathophysiology and Treatment","volume":"1","author":"Nicolaou","year":"2024","journal-title":"Lipidology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0043-1768976","article-title":"Free Communications of The Seventh Qatar Diabetes, Endocrinology, and Metabolic Conference, Doha, Qatar, March 2\u20134, 3\u20135, 2023","volume":"6","author":"Bashir","year":"2023","journal-title":"J. Diabetes Endocr. Pract."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2006.16.563","article-title":"Thyroid disorders in chronic hepatitis C virus infection","volume":"16","author":"Antonelli","year":"2006","journal-title":"Thyroid"},{"key":"ref_64","first-page":"e18289","article-title":"Prevalence of thyroid dysfunction in patients with hepatitis c","volume":"13","author":"Nazary","year":"2021","journal-title":"Cureus"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.32604\/biocell.2022.022257","article-title":"Long term immunological perturbations post DAA therapy in chronic HCV\/HIV co-infected patients","volume":"46","author":"Moretti","year":"2022","journal-title":"Biocell"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Apol, \u00c1.D., S\u00f8lund, C.S., Vinten, C.A.N., Underwood, A., Bukh, J., and Weis, N. (2025). Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: A systematic review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1546915"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e000203","DOI":"10.1136\/bmjgast-2018-000203","article-title":"Autoantibodies in chronic hepatitis C virus infection: Impact on clinical outcomes and extrahepatic manifestations","volume":"5","author":"Gilman","year":"2018","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00024677-200403040-00005","article-title":"Subclinical hypothyroidism and cardiovascular risk: A reason to treat?","volume":"3","author":"Palmieri","year":"2004","journal-title":"Treat. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2012.492","article-title":"Metabolic syndrome and hepatocellular carcinoma risk","volume":"108","author":"Turati","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","article-title":"Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV","volume":"22","author":"Lonardo","year":"2016","journal-title":"World J. Gastroenterol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/2\/104\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:18:49Z","timestamp":1770196729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/2\/104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["metabo16020104"],"URL":"https:\/\/doi.org\/10.3390\/metabo16020104","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}